symptoms of anxiety

Distressed Personality Without a Partner Enhances the Risk of Depression in Patients With Coronary Heart Disease.

Published July 18, 2013

Distressed personality without a partner enhances the risk of depression in patients with coronary heart disease.

Asia Pac Psychiatry. 2012 Dec 5;
Lim HE, Lee MS, Ko YH, Park YM, Han C, Joe SH

Cultural differences in the combined… Continue reading →

Effectiveness of Massage Therapy on the Mood of Patients After Open-Heart Surgery.

Published July 9, 2013

Effectiveness of massage therapy on the mood of patients after open-heart surgery.

Iran J Nurs Midwifery Res. 2012 Feb; 17(2 Suppl 1): S120-4
Babaee S, Shafiei Z, Sadeghi MM, Nik AY, Valiani M

Cardiovascular diseases have the highest death… Continue reading →

Clinical and Reliable Change in an Australian Residential Substance Use Program Using the Addiction Severity Index.

Published July 3, 2013

Clinical and Reliable Change in an Australian Residential Substance Use Program Using the Addiction Severity Index.

J Addict Dis. 2013 April-June; 32(2): 194-205
Deane FP, Kelly PJ, Crowe TP, Coulson JC, Lyons GC

Although the Addiction Severity Index (ASI)… Continue reading →

Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial.

Published June 29, 2013

Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial.

J Palliat Med. 2013 Jun 27;
Irwin SA, Iglewicz A, Nelesen RA, Lo JY, Carr CH, Romero SD, Lloyd… Continue reading →

No Dishonour in Depression.

Published June 19, 2013

No dishonour in depression.

Nature. 2013 Jun 13; 498(7453): 137

HubMed – depression

Role of aqueous extract of Azadirachta indica leaves in an experimental model of Alzheimer’s disease in rats.

Int J Appl Basic Med Res. 2013… Continue reading →

Motivational Disturbances and Effects of L-Dopa Administration in Neurofibromatosis-1 Model Mice.

Published June 14, 2013

Motivational Disturbances and Effects of L-dopa Administration in Neurofibromatosis-1 Model Mice.

PLoS One. 2013; 8(6): e66024
Wozniak DF, Diggs-Andrews KA, Conyers S, Yuede CM, Dearborn JT, Brown JA, Tokuda K, Izumi Y, Zorumski CF, Gutmann DH

Children with neurofibromatosis… Continue reading →

Selenium Supplementation for Hashimoto’s Thyroiditis.

Published June 8, 2013

Selenium supplementation for Hashimoto’s thyroiditis.

Cochrane Database Syst Rev. 2013 Jun 6; 6: CD010223
van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H

BACKGROUND: Hashimoto’s thyroiditis is a common auto-immune disorder. The most common presenting symptoms may… Continue reading →

Red Flags for Persistent or Worsening Anxiety and Depression After an Acute Cardiac Event: A 6-Month Longitudinal Study in Regional and Rural Australia.

Published June 5, 2013

Red flags for persistent or worsening anxiety and depression after an acute cardiac event: a 6-month longitudinal study in regional and rural Australia.

Eur J Prev Cardiol. 2013 Jun 3;
Murphy B, Ludeman D, Elliott P, Judd F, Humphreys… Continue reading →

Do Hormone Treatments for Prostate Cancer Cause Anxiety and Depression?

Published June 4, 2013

Do hormone treatments for prostate cancer cause anxiety and depression?

Int J Clin Oncol. 2013 Jun 1;
Sharpley CF, Christie DR, Bitsika V

BACKGROUND: To investigate the relationship between hormone therapy (HT) and incidence of anxiety and depression among… Continue reading →

DEPRESSION SYMPTOMS SOLUTIONS- DEPRESSION SYMPTOMS, TYPES and TREATMENT

Published May 21, 2013

DEPRESSION SYMPTOMS SOLUTIONS- DEPRESSION SYMPTOMS, TYPES AND TREATMENT – http://depressionmagic.com/ Depression Symptoms Solutions- Depression Symptoms, Types And Treatment – Mental Depression – Depression Treatment – Major Depres…

Art Therapy Effective For Psychological Symptoms Among Cancer Patients, But …… Continue reading →